CMS Issued Guidance on Biosimilars
- FLASCO
- May 3, 2015
- Drugs
CMS Issued Guidance on Biosimilars
Please review CMS Coverage of Biosimilars for more information.
See new codes below:
HCPCS Code | Short Description | Long Description | Action | Coverage | Pricing | Effective Date | |||||
Q5101 | Inj filgrastim g-csf biosim | Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram | Add | D | 51 | 7/1/2015 | |||||
Q9976 | Inj Ferric Pyrophosphate Cit | Injection, Ferric Pyrophosphate Citrate Solution, 0.1 mg of iron | Add | C | 51 | 7/1/2015 | |||||
Q9977 | Compounded Drug NOC | Compounded Drug, Not Otherwise Classsified | Add | D | 51 | 7/1/2015 | |||||
JF | Compounded Drug | Compounded Drug | Discontinue | C | 6/30/2015 | ||||||
Q9978 | Netupitant Palonosetron oral | Netupitant 300 mg and Palonosetron 0.5 mg, oral | Add | D | 51 | 7/1/2015 | |||||
S8262 | Mandib ortho repos device | Mandibular Orthopedic Repositioning Device, Each | Discontinue | I | 0 | 6/30/2015 | |||||